These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36795053)

  • 21. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery.
    Morrison D; Paldus B; Zaharieva DP; Lee MH; Vogrin S; Jenkins AJ; Gerche A; MacIsaac RJ; McAuley SA; Ward GM; Colman PG; Smart CEM; Seckold R; Grosman B; Roy A; King BR; Riddell MC; O'Neal DN
    Diabetes Technol Ther; 2022 Dec; 24(12):873-880. PubMed ID: 36094458
    [No Abstract]   [Full Text] [Related]  

  • 24. Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall.
    Riddell MC; Zaharieva DP; Tansey M; Tsalikian E; Admon G; Li Z; Kollman C; Beck RW
    Pediatr Diabetes; 2019 Feb; 20(1):99-106. PubMed ID: 30467929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge.
    Kordonouri O; Vazeou A; Scharf M; Würsig M; Battelino T;
    Acta Diabetol; 2017 Apr; 54(4):403-409. PubMed ID: 28154987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No Disadvantage to Insulin Pump Off vs Pump On During Intermittent High-Intensity Exercise in Adults With Type 1 Diabetes.
    Zaharieva DP; Cinar A; Yavelberg L; Jamnik V; Riddell MC
    Can J Diabetes; 2020 Mar; 44(2):162-168. PubMed ID: 31416695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Type 1 Diabetes and EXercise Initiative: Predicting Hypoglycemia Risk During Exercise for Participants with Type 1 Diabetes Using Repeated Measures Random Forest.
    Bergford S; Riddell MC; Jacobs PG; Li Z; Gal RL; Clements MA; Doyle FJ; Martin CK; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Calhoun P
    Diabetes Technol Ther; 2023 Sep; 25(9):602-611. PubMed ID: 37294539
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
    Crabtree TSJ; Griffin TP; Yap YW; Narendran P; Gallen G; Furlong N; Cranston I; Chakera A; Philbey C; Karamat MA; Saraf S; Kamaruddin S; Gurnell E; Chapman A; Hussain S; Elliott J; Leelarathna L; Ryder REJ; Hammond P; Lumb A; Choudhary P; Wilmot EG;
    Diabetes Care; 2023 Oct; 46(10):1831-1838. PubMed ID: 37566697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes.
    Petrovski G; Al Khalaf F; Campbell J; Fisher H; Umer F; Hussain K
    Acta Diabetol; 2020 Jun; 57(6):681-687. PubMed ID: 31953687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
    Davis GM; Peters AL; Bode BW; Carlson AL; Dumais B; Vienneau TE; Huyett LM; Ly TT
    Diabetes Care; 2023 Apr; 46(4):742-750. PubMed ID: 36787903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
    Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms.
    Nattero-Chávez L; Lecumberri Pascual E; De La Calle E; Bayona Cebada A; Ruiz T; Quintero Tobar A; Lorenzo M; Sánchez C; Izquierdo A; Luque-Ramírez M; Escobar-Morreale HF
    Diabetes Res Clin Pract; 2023 May; 199():110627. PubMed ID: 36940793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study.
    Ivandic M; Cigrovski Berkovic M; Ormanac K; Sabo D; Omanovic Kolaric T; Kuna L; Mihaljevic V; Canecki Varzic S; Smolic M; Bilic-Curcic I
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study.
    Moniotte S; Owen M; Barrea T; Robert A; Lysy PA
    Pediatr Diabetes; 2017 Dec; 18(8):925-933. PubMed ID: 28251726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study.
    Nørgaard K; Ranjan AG; Laugesen C; Tidemand KG; Green A; Selmer C; Svensson J; Andersen HU; Vistisen D; Carstensen B
    Diabetes Care; 2023 Nov; 46(11):1958-1964. PubMed ID: 37610784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.